Market Overview

Morning Market Losers

Share:
Related SNTA
Morning Market Losers
Synta Announces Termination for Futility of Ganetespib Phase 3 GALAXY-2 Trial in Lung Cancer
Related INFI
Mid-Afternoon Market Update: Crude Oil Slides Over 2%; MannKind Shares Dip On Termination Of Afrezza Deal With Sanofi
Stocks Hitting 52-Week Lows
Combination Of Infinity Pharma And AbbVie Could Be A Big Winner For The Adventurous Stock Investor (Seeking Alpha)

Synta Pharmaceuticals (NASDAQ: SNTA) shares dipped 32.93% to $4.95 after the company reported positive overall survival results from GALAXY-1 Phase 2b/3 trial of ganetespib in second-line non-small cell lung cancer.

Infinity Pharmaceuticals (NASDAQ: INFI) shares lost 23.41% to $20.64 on Phase 1 data.

Affymax (NASDAQ: AFFY) fell 22.60% to $1.61. Affymax's PEG ratio is -0.17.

National Bank of Greece SA (NYSE: NBG) dropped 12.60% to $6.31. The bank's trailing-twelve-month profit margin is -98.37%

Posted-In: Morning Market LosersNews Movers & Shakers Intraday Update Markets

 

Related Articles (AFFY + INFI)

View Comments and Join the Discussion!

Get Benzinga's Newsletters